Skip to main content
  • Saved

made a Post

Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma

Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma

Source :

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481595/

Hualin Chen, 1 Meilian Liu, 1 Zhiwei Dai, 1 Shujun Li, 1 Yiping Luo, 1 Yongcun Wang, 1 Wenmei Su, 1 Weijing Cai, 2 Donghong Yang, 3 Jian Huang, 4 and Zhixiong Yang 1 Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are considered to be more effective than chemotherapy in the treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC).